Zhih‐Cherng Chen

1.8k total citations
84 papers, 1.1k citations indexed

About

Zhih‐Cherng Chen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Zhih‐Cherng Chen has authored 84 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 21 papers in Molecular Biology. Recurrent topics in Zhih‐Cherng Chen's work include Cardiovascular Function and Risk Factors (17 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Heart Failure Treatment and Management (7 papers). Zhih‐Cherng Chen is often cited by papers focused on Cardiovascular Function and Risk Factors (17 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Heart Failure Treatment and Management (7 papers). Zhih‐Cherng Chen collaborates with scholars based in Taiwan, United States and Japan. Zhih‐Cherng Chen's co-authors include Wei‐Ting Chang, Juei‐Tang Cheng, Jhih‐Yuan Shih, Chung‐Han Ho, Yu‐Wen Lin, Jhi‐Joung Wang, Kai‐Chun Cheng, Ho‐Shan Niu, Chao‐Tien Hsu and Chung‐Feng Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Zhih‐Cherng Chen

80 papers receiving 1.1k citations

Peers

Zhih‐Cherng Chen
Il Suk Sohn South Korea
Mark Donahue United States
Anna P. Pilbrow New Zealand
Danny J. Eapen United States
Zhih‐Cherng Chen
Citations per year, relative to Zhih‐Cherng Chen Zhih‐Cherng Chen (= 1×) peers Xiaolei Yang

Countries citing papers authored by Zhih‐Cherng Chen

Since Specialization
Citations

This map shows the geographic impact of Zhih‐Cherng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhih‐Cherng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhih‐Cherng Chen more than expected).

Fields of papers citing papers by Zhih‐Cherng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhih‐Cherng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhih‐Cherng Chen. The network helps show where Zhih‐Cherng Chen may publish in the future.

Co-authorship network of co-authors of Zhih‐Cherng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhih‐Cherng Chen. A scholar is included among the top collaborators of Zhih‐Cherng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhih‐Cherng Chen. Zhih‐Cherng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Wei‐Chieh, Yu‐Wen Lin, Jhih‐Yuan Shih, et al.. (2024). Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model. SHILAP Revista de lepidopterología. 25(3). 608–622. 2 indexed citations
2.
Shih, Jhih‐Yuan, Yu‐Wen Lin, Ko‐Chi Niu, et al.. (2024). Hyperbaric Oxygen Therapy Improved Neovascularisation Following Limb Ischaemia—The Role of ROS Mitigation. Journal of Cellular and Molecular Medicine. 28(24). e70310–e70310. 1 indexed citations
3.
Chang, Wei‐Ting, Chia-Chun Wu, Yu‐Wen Lin, et al.. (2023). Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway—A translational study. Free Radical Biology and Medicine. 208. 103–111. 11 indexed citations
4.
Chang, Wei‐Ting, Wei‐Chieh Lee, Yu‐Wen Lin, et al.. (2023). Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease–Related Pulmonary Arterial Hypertension. Journal of the American Heart Association. 12(23). e031435–e031435. 9 indexed citations
5.
Lee, Wei‐Chieh, et al.. (2023). Ivabradine Could Not Decrease Mitral Regurgitation Triggered Atrial Fibrosis and Fibrillation Compared with Carvedilol. ESC Heart Failure. 11(1). 251–260. 5 indexed citations
6.
Chen, Chia‐Jung, Yuting Shen, Chien‐Chin Hsu, et al.. (2023). Real‐time artificial intelligence predicts adverse outcomes in acute pancreatitis in the emergency department: Comparison with clinical decision rule. Academic Emergency Medicine. 31(2). 149–155. 11 indexed citations
7.
Chang, Wei‐Ting, Chung‐Feng Liu, Yin‐Hsun Feng, et al.. (2022). An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline. Archives of Toxicology. 96(10). 2731–2737. 27 indexed citations
8.
Chen, Yi‐Chen, Chung‐Han Ho, Michael Chen, et al.. (2022). Association of Gonadotropin-Releasing Hormone Therapies With Venous Thromboembolic Events in Patients With Prostate Cancer: A National Cohort Study. Frontiers in Cardiovascular Medicine. 9. 794310–794310. 1 indexed citations
9.
Chen, Michael, Jhih‐Yuan Shih, Chung‐Han Ho, et al.. (2021). Effects of renal impairment on cardiac remodeling and clinical outcomes after myocardial infarction. International Journal of Medical Sciences. 18(13). 2842–2848. 5 indexed citations
10.
Chang, Wei‐Ting, Jhih‐Yuan Shih, Yu‐Wen Lin, et al.. (2021). Right Ventricular Expression of NT-proBNP Adds Predictive Value to REVEAL Score in Patients with Pulmonary Arterial Hypertension. ESC Heart Failure. 8(4). 3082–3092. 5 indexed citations
11.
Liao, Chia‐Te, Han Siong Toh, Wei‐Ting Chang, et al.. (2020). Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases. Cardiovascular Drugs and Therapy. 35(3). 539–547. 6 indexed citations
12.
Chang, Wei‐Ting, et al.. (2020). Right ventricular reserve post mitral valve repair is associated with heart failure hospitalization. Pulmonary Circulation. 10(4). 1–10. 5 indexed citations
13.
Chang, Wei‐Ting, Yu-Wen Lin, Chung‐Han Ho, et al.. (2020). Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients. Archives of Toxicology. 95(2). 659–671. 57 indexed citations
14.
Cheng, Kai‐Chun, Wei‐Ting Chang, Feng Yu Kuo, et al.. (2019). TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells. Scientific Reports. 9(1). 3633–3633. 43 indexed citations
15.
Cheng, Kai‐Chun, et al.. (2018). Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models. Journal of Food and Drug Analysis. 27(1). 355–364. 11 indexed citations
16.
17.
Ho, Chung‐Han, et al.. (2018). Radial artery occlusion with a kaolin-filled pad after transradial cardiac catheterization. Medicine. 97(46). e13134–e13134. 2 indexed citations
18.
Cheng, Kai‐Chun, Yingxiao Li, Wei‐Ting Chang, et al.. (2018). Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report. Diabetes Metabolic Syndrome and Obesity. Volume 11. 901–911. 12 indexed citations
19.
Lo, Shih‐Hsiang, Chao‐Tien Hsu, Ho‐Shan Niu, et al.. (2017). Cryptotanshinone Inhibits STAT3 Signaling to Alleviate Cardiac Fibrosis in Type 1-like Diabetic Rats. Phytotherapy Research. 31(4). 638–646. 40 indexed citations
20.
Lien, Li-Ming, Zhih‐Cherng Chen, Chi‐Li Chung, et al.. (2014). Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo. European Journal of Pharmacology. 737. 159–167. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026